Exact Mass: 366.1566
Exact Mass Matches: 366.1566
Found 329 metabolites which its exact mass value is equals to given mass value 366.1566
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Rilpivirine
Rilpivirine belongs to the class of organic compounds known as nitrotoluenes. These are organic aromatic compounds containing a benzene that carries a single methyl group and at least 1 nitro group. J - Antiinfectives for systemic use > J05 - Antivirals for systemic use > J05A - Direct acting antivirals > J05AG - Non-nucleoside reverse transcriptase inhibitors C471 - Enzyme Inhibitor > C1589 - Reverse Transcriptase Inhibitor > C97453 - Non-nucleoside Reverse Transcriptase Inhibitor D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D018894 - Reverse Transcriptase Inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents D004791 - Enzyme Inhibitors > D019384 - Nucleic Acid Synthesis Inhibitors C254 - Anti-Infective Agent > C281 - Antiviral Agent
Curcumin II
Curcumin II is found in herbs and spices. Curcumin II is isolated from the rhizomes of Curcuma longa (turmeric). Isolated from the rhizomes of Curcuma longa (turmeric). Curcumin II is found in turmeric and herbs and spices.
1-[(1R,2R,3S,4S)-3-Hydroxy-4,7,7-trimethyl-2-bicyclo[2.2.1]heptanyl]-3-(4-methylphenyl)sulfonylurea
(E)-4-(4-(4-(2-Cyanovinyl)-2,6-dimethylphenylamino)pyrimidin-2-ylamino)benzonitrile
Xanthoangelol C
Xanthoangelol c is a member of the class of compounds known as 3-prenylated chalcones. 3-prenylated chalcones are chalcones featuring a C5-isoprenoid unit at the 3-position. Thus, xanthoangelol c is considered to be a flavonoid lipid molecule. Xanthoangelol c is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Xanthoangelol c can be found in angelica, which makes xanthoangelol c a potential biomarker for the consumption of this food product.
Glyflavanone A
An extended flavonoid that is 2,3-dihydro-4H,8H-pyrano[2,3-f]chromen-4-one which is substituted by a p-methoxyphenyl group at the 2-pro-S position, a methoxy group at position 5, and two methyl groups at position 8.
6,6-Dimethylpyrano[2,3:6,5]-2-hydroxy-4,4-dimethoxychalcone
Praecansone B
cis-Tephrostachin
GLIBORNURIDE
A - Alimentary tract and metabolism > A10 - Drugs used in diabetes > A10B - Blood glucose lowering drugs, excl. insulins > A10BB - Sulfonylureas C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C97936 - Sulfonylurea Antidiabetic Agent D007004 - Hypoglycemic Agents
2-(3,4-Dimethoxyphenyl)-8,8-dimethyl-2,3-dihydro-4H,8H-benzo[1,2-b:3,4-b]dipyran-4-one
(1alpha,2alpha,3beta,4beta,6beta,8alpha,9alpha)-1,2,3,4,6,8,9,13,14-Nonahydroxydihydro-beta-agarofuran|Euonyminol|Euonyminol?
1-(5-hydroxy-7-methoxy-2,2-dimethyl-2H-chromen-6-yl)-3-(4-methoxyphenyl)propenone|2-methoxy-4,6-dihydroxylonchocarpin|glychalcone A|glychalcone-A
methyl (1S,10R,12S,19S)-12-ethenyl-4-hydroxy-9-oxo-8,16-diazapentacyclo[10.6.1.0^{1,10.0^{2,7.0^{16,19]nonadeca-2(7),3,5,13-tetraene-10-carboxylate
2-hydroxy-4,4-dimethoxy-5,6-(2,2-dimethylpyrano)chalcone
2,2-Dimethyl-5-hydroxy-8-(3-hydroxy-4-methoxyphenyl)-6,7,8,9-tetrahydro-2H-naphtho[2,3-b]pyran-6-one
3-butenyl 6-O-(alpha-L-arabinopyranosyl)-beta-D-glucopyranoside
19(E)-18-demethoxygardfloramine
A natural product found in Gardneria ovata.
2-(4-methylpentanoyl)-1-hydroxy-8-methoxy-3-methylanthracene-9,10-dione|fistulaquinone A
10-hydroxyisovallesiachotamine|methyl (2S,12bS)-1,2,6,7,12,12b-hexahydro-9-hydroxy-2-[(2E)-1-oxobut-2-en-2-yl]indolo[2,3-a]quinolizine-3-carboxylate
2,5-dimethoxy-3,6-di(p-methoxyphenyl)phenol|2?-hydroxy-4,6?,3?,4-tetramethoxy-p-terphenyl|4,3,6,4-Tetramethoxy-5-hydroxy-p-terphenyl
(E)-3-(3,4-dimethoxyphenyl)-1-(5-hydroxy-2,2-dimethyl-2H-chromen-6-yl)prop-2-en-1-one|3,4-dimethoxy-2-hydroxy-6,6-dimethylchromeno-[2,3:4,3]-chalcone
(RS)-Plectranthon B ( = (RS)-<2-(3-Hydroxy-5,7,8-trimethyl-1,4-dioxophenanthren-2-yl)-1-methylethyl>-acetat)|(RS)-Plectranthon B { = (RS)-[2-(3-Hydroxy-5,7,8-trimethyl-1,4-dioxophenanthren-2-yl)-1-methylethyl]-acetat}|plectranthon B|Plectranthone B
12,16-Dihydroxystrychnine|3,12-dihydroxystrychnine|4,16-Dihydroxystrychnin
(3R)-5-hydroxy-6,7-(2,2-dimethylchromene)-3-(4-methoxybenzyl)-4-chromanone|ledebourin A
(+/-)-5-methoxy-2-(4-methoxyphenyl)-8,8-dimethyl-2,3-dihydro-8H-pyrano[2,3-f]chromen-4-one|(+/-)-glyflavanone-A
(E)-1-(3-chloro-6-(3,7-dimethylocta-2,6-dienyloxy)-2,4-dihydroxyphenyl)butan-1-one
Di-O-methyldemethoxycurcumin
Di-O-methyldemethoxycurcumin, a curcuminoid analog, inhibits IL-6 production with an EC50 of 16.20 μg/mL. Anti-inflammatory and antioxidant properties[1].
Ala Gly Gly Tyr
Ala Gly Tyr Gly
Ala Tyr Gly Gly
Phe Gly Gly Ser
Phe Gly Ser Gly
Phe Ser Gly Gly
Gly Ala Gly Tyr
Gly Ala Tyr Gly
Gly Phe Gly Ser
Gly Phe Ser Gly
Gly Gly Ala Tyr
Gly Gly Phe Ser
Gly Gly His Pro
Gly Gly Pro His
Gly Gly Ser Phe
Gly Gly Tyr Ala
Gly His Gly Pro
Gly His Pro Gly
Gly Pro Gly His
Gly Pro His Gly
Gly Ser Phe Gly
Gly Ser Gly Phe
Gly Tyr Ala Gly
Gly Tyr Gly Ala
His Gly Gly Pro
His Gly Pro Gly
His Pro Gly Gly
Pro Gly Gly His
Pro Gly His Gly
Pro His Gly Gly
Ser Phe Gly Gly
Ser Gly Phe Gly
Ser Gly Gly Phe
Tyr Ala Gly Gly
Tyr Gly Ala Gly
Tyr Gly Gly Ala
[8-[(4-amino-2-nitrophenyl)azo]-7-hydroxy-2-naphthyl]trimethylammonium
methyl 4-chloro-1-[tris(propan-2-yl)silyl]-1H-pyrrolo[2,3-b]pyridine-5-carboxylate
4-(4-fluoro-3-(piperazine-1-carbonyl)benzyl)phthalazin-1(2H)-one
(2E)-2-(5,6-Dimethoxy-2,3-dihydro-1H-inden-1-ylidene)-5,6-dimethoxy-1-indanone
Trihydridobis(pentaMethylcyclopentadienyl)niobiuM(V)
(3aR,4S,6R,6aS)-6-[7-Amino-5-(propylthio)-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]tetrahydro-2,2-dimethyl-4H-cyclopenta-1,3-dioxol-4-ol
3,4:5,6-Di-O-isopropylidene-D-glucose diethyl mercaptal
Urea, 1-(2-hydroxy-3-bornyl)-3-(p-tolylsulfonyl)-, (1R,2R,3S,4S)-
4-(6-Methyl-4-phenyl-2-quinazolinyl)-1,3-dihydroquinoxalin-2-one
[amino-[2-[(6-carbamimidoyl-1H-benzimidazol-2-yl)-dihydroxymethyl]-3H-benzimidazol-1-ium-5-yl]methylidene]azanium
Rilpivirine
J - Antiinfectives for systemic use > J05 - Antivirals for systemic use > J05A - Direct acting antivirals > J05AG - Non-nucleoside reverse transcriptase inhibitors C471 - Enzyme Inhibitor > C1589 - Reverse Transcriptase Inhibitor > C97453 - Non-nucleoside Reverse Transcriptase Inhibitor D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D018894 - Reverse Transcriptase Inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents D004791 - Enzyme Inhibitors > D019384 - Nucleic Acid Synthesis Inhibitors C254 - Anti-Infective Agent > C281 - Antiviral Agent
1-[[3-(9-Carbazolyl)-1-oxopropyl]amino]-3-(2-methylprop-2-enyl)thiourea
N-(4-((1,1-Biphenyl)-4-ylamino)quinazolin-6-yl)acrylamide
4-(1H-indol-3-yl)butanoic acid [2-(3-methoxyanilino)-2-oxoethyl] ester
4-(1,3-dioxo-2-isoindolyl)-N-[2-(4-methoxyphenyl)ethyl]butanamide
4-(3-Methoxyanilino)-2-methyl-5-oxo-1-phenyl-2-pyrrolecarboxylic acid ethyl ester
N-[(8-methyl-2-oxo-1H-quinolin-3-yl)methyl]-N-(2-oxolanylmethyl)-2-furancarboxamide
1-Butyl-3-[[2-oxo-1-(phenylmethyl)-3-indolylidene]amino]thiourea
N-[6-ethyl-6-methyl-2-(methylthio)-5,8-dihydropyrano[4,5]thieno[1,2-c]pyrimidin-4-yl]-N,N-dimethylethane-1,2-diamine
N-[(E)-(4-Methylphenyl)methylideneamino]-2-pyridin-3-ylquinoline-4-carboxamide
2-(2-amino-1-benzimidazolyl)-N-(phenylmethyl)-4-quinazolinamine
N-ethyl-N-[[(2S,3R,4R)-4-(hydroxymethyl)-1-methylsulfonyl-3-phenyl-2-azetidinyl]methyl]cyclopropanecarboxamide
N-ethyl-N-[[(2S,3R,4S)-4-(hydroxymethyl)-1-methylsulfonyl-3-phenyl-2-azetidinyl]methyl]cyclopropanecarboxamide
N-ethyl-N-[[(2R,3S,4S)-4-(hydroxymethyl)-1-methylsulfonyl-3-phenyl-2-azetidinyl]methyl]cyclopropanecarboxamide
1-[[4-[(S)-(3-chlorophenyl)-imidazol-1-ylmethyl]phenyl]methyl]piperazine
[2-Propanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropyl] propanoate
[1-Acetyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] butanoate
2-(Phenylethynyl)-2-(para-tolyl)-hexamethyltrisilane
1-(Meta-tolyl)-1,2-bis(trimethylsilyl)-1-silaindene
2-Ethyl-1,1,2,3,3-pentamethyl-4,5-diphenyl-1,2,3-trisilacyclopenta-4-ene
1-(2,2,2-Trimethyl-1-phenyl-1-(o-tolyl)disilanyl)-2-(trimethylsilyl)acetylene
COTI-2
COTI-2, an anti-cancer agent with low toxicity, is an orally available third generation activator of p53 mutant forms. COTI-2 acts both by reactivating mutant p53 and inhibiting the PI3K/AKT/mTOR pathway. COTI-2 induces apoptosis in multiple human tumor cell lines. COTI-2 exhibits antitumor activity in HNSCC through p53-dependent and -independent mechanisms. COTI-2 converts mutant p53 to wild-type conformation[1][2][3].
(2s)-2-[(1ar,1bs,3as,5r,7bs,9as)-1a,5,7b-trimethyl-1h,1bh,2h,3h,3ah,4h,6h,8h,9h,9ah-cyclopropa[a]phenanthren-5-yl]-2-bromoethanol
methyl (1r,9s,11s,14z,15s,17s,19r)-14-ethylidene-19-formyl-18-oxa-2,12-diazahexacyclo[9.6.1.1⁹,¹⁵.0¹,⁹.0³,⁸.0¹²,¹⁷]nonadeca-3,5,7-triene-19-carboxylate
methyl 3-(4-{[4-(buta-2,3-dien-1-yloxy)phenyl]methoxy}-3-methoxyphenyl)prop-2-enoate
2-(3,4-dimethoxyphenyl)-8,8-dimethyl-2h,3h-pyrano[2,3-f]chromen-4-one
methyl 5-(hydroxymethyl)-6-methyl-4-{9h-pyrido[3,4-b]indol-1-ylmethyl}-5,6-dihydro-4h-pyran-3-carboxylate
(8r)-5-hydroxy-8-(3-hydroxy-4-methoxyphenyl)-2,2-dimethyl-7h,8h,9h-cyclohexa[g]chromen-6-one
8-methoxy-3-(4-methoxyphenyl)-7-[(3-methylbut-2-en-1-yl)oxy]chromen-4-one
1-(5,7-dimethoxy-2,2-dimethylchromen-6-yl)-3-hydroxy-3-phenylprop-2-en-1-one
(1s,2r,3s,9r)-5-acetyl-4-hydroxy-8,8,16-trimethyl-7,16-diazapentacyclo[9.6.1.0²,⁹.0³,⁷.0¹⁵,¹⁸]octadeca-4,11(18),12,14-tetraene-6,17-dione
methyl (1r,9s,11s,14e,15s,17s,19s)-14-ethylidene-19-formyl-18-oxa-2,12-diazahexacyclo[9.6.1.1⁹,¹⁵.0¹,⁹.0³,⁸.0¹²,¹⁷]nonadeca-3,5,7-triene-19-carboxylate
2-{1a,5,7b-trimethyl-1h,1bh,2h,3h,3ah,4h,6h,8h,9h,9ah-cyclopropa[a]phenanthren-5-yl}-2-bromoethanol
5-hydroxy-8-(3-hydroxy-4-methoxyphenyl)-2,2-dimethyl-7h,8h,9h-cyclohexa[g]chromen-6-one
2-[(1r,2e,3s,12br)-3-ethyl-1-formyl-1h,3h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizin-2-ylidene]-3-oxopropanoic acid
3-(4-hydroxy-3,5-dimethoxyphenyl)-n-[2-(1h-indol-3-yl)ethyl]prop-2-enimidic acid
(2r)-2-[(1as,1bs,5r,7as,7bs,9ar)-1a,5,7b-trimethyl-1h,1bh,2h,4h,6h,7h,7ah,8h,9h,9ah-cyclopropa[a]phenanthren-5-yl]-2-bromoethanol
(2s,3r)-16-hydroxy-8,10-dioxa-13,19-diazaoctacyclo[12.8.2.1¹,¹⁶.0²,¹⁹.0³,¹⁴.0³,¹⁷.0⁴,¹².0⁷,¹¹]pentacosa-4,6,11-trien-15-one
methyl (1s,9z,12s,13z)-12-formyl-12-methyl-19-oxo-8,16-diazatetracyclo[14.2.1.0¹,⁹.0²,⁷]nonadeca-2,4,6,9,13-pentaene-10-carboxylate
3-butenyl-6'-o-α-l-arabinopyranosyl-β-d-gluco-pyranoside
{"Ingredient_id": "HBIN008350","Ingredient_name": "3-butenyl-6'-o-\u03b1-l-arabinopyranosyl-\u03b2-d-gluco-pyranoside","Alias": "NA","Ingredient_formula": "C15H26O10","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "2781","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
anticancer flavonoid pmv70p691-107
{"Ingredient_id": "HBIN016335","Ingredient_name": "anticancer flavonoid pmv70p691-107","Alias": "NA","Ingredient_formula": "C22H22O5","Ingredient_Smile": "CC1(C=CC2=C(C(=C(C=C2O1)OC)C(=O)CC(=O)C3=CC=CC=C3)OC)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "1410","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}